US FDA Commissioner Tries To Allay Concerns About Inspection Postponements
Screenings at ports of entry may be modified, but the drug supply remains safe and secure, Stephen Hahn tells House Committee, arguing that other tools will allow for continued facility policing during the coronavirus outbreak even if the absence of inspections.
You may also be interested in...
Agency appears to have a fair bit of flexibility in how to spend the additional $80m slated for coronavirus activities.
An additional $160m is allocated to FDA in House coronavirus-related stimulus bill aimed at fighting the pandemic and helping the wobbling economy. It would not, as a similar Senate bill proposes, once again allow using pre-tax savings accounts to buy OTC drugs.
Every new FDA commissioner faces a challenge earning credibility with Congress and the public, but in the context of COVID-19, Stephen Hahn has a double challenge of a public health crisis – and the ongoing prominence of his predecessor at the agency.